6505--CAMPHOR_MENTHOL_METHYL SALICYLATE PATCH
ID: 36C77025Q0172Type: Presolicitation
Overview

Buyer

VETERANS AFFAIRS, DEPARTMENT OFVETERANS AFFAIRS, DEPARTMENT OFNATIONAL CMOP OFFICE (36C770)LEAVENWORTH, KS, 66048, USA

NAICS

Pharmaceutical Preparation Manufacturing (325412)

PSC

DRUGS AND BIOLOGICALS (6505)

Set Aside

Total Small Business Set-Aside (FAR 19.5) (SBA)

Original Source

https://sam.gov/opp/1fa7a87a4c5848bca3ee46e962374b61/view
Timeline
    Description

    The Department of Veterans Affairs is soliciting proposals for the procurement of Camphor-Menthol-Methyl Salicylate Patches, aimed at enhancing the medical supplies available for veterans. This Request for Proposals (RFP) outlines the need for pharmaceutical supplies, emphasizing compliance with federal regulations, including product labeling and delivery schedules, while prioritizing small businesses, particularly those owned by veterans or women. The patches are essential for providing pain relief to veterans, ensuring they receive effective treatment options. Interested bidders must submit their proposals, including pricing and required documentation, to Contract Specialist Larry M Zaritz at larry.zaritz@va.gov, with the procurement being unrestricted and adhering to the Drug Supply Chain Security Act.

    Point(s) of Contact
    Larry ZaritzContracting Officer
    (913) 684-0156
    larry.zaritz@va.gov
    Files
    Title
    Posted
    36C77025Q0172_1.docx
    The Department of Veterans Affairs (VA) is soliciting bids for the procurement of CAMPHOR/MENTHOL/METHYL SALICYLATE PATCH, specifically for 14,322 boxes of 60 count each, to be delivered to several Consolidated Mail Outpatient Pharmacies (CMOPs) across the country. The solicitation number is 36C77025Q0172, with a response deadline set for March 7, 2025, at 10:00 AM CST. This contract is set aside for small businesses under the SBA guidelines. Vendors must provide a comprehensive quotation detailing the price schedule and complete required documentation, including a state wholesale distributor license to comply with the Drug Supply Chain Security Act (DSCSA). The acquisition will be executed through the SAM.gov platform, where all solicitation details will be posted. The delivery will be made to multiple CMOP sites nationwide, with vendors responsible for specifying their delivery dates and shipping costs. Additional information and required forms must be submitted via email to the primary contact, Contracting Officer Larry Zaritz. This presolicitation notice outlines the essential steps and documentation necessary for prospective bidders, emphasizing adherence to compliance and regulations.
    36C77025Q0172.docx
    The document is a Request for Proposals (RFP) issued by the Department of Veterans Affairs for procurement of pharmaceutical supplies, specifically the Camphor-Menthol-Methyl Salicylate Patch (C1625). It outlines the solicitation details including order numbers, delivery requirements, and submission instructions. The procurement is set as unrestricted with a preference for small businesses, especially those owned by veterans or women. Bidders must provide required documentation including pricing, quantities, and National Drug Codes (NDCs) in their proposals. Additionally, the document specifies compliance with various federal acquisition regulations, including requirements for product labeling, delivery schedules and the Drug Supply Chain Security Act. It mandates that all products be U.S.-made where possible and emphasizes adherence to safety and labeling standards. Furthermore, the RFP establishes clear communication protocols for recalls and delivery logistics while ensuring that invoices must be submitted electronically. The overall purpose of the document is to facilitate the acquisition of necessary medical products for veterans efficiently and in compliance with established regulatory frameworks, thereby enhancing the operational capabilities of the VA's healthcare provisions.
    Lifecycle
    Title
    Type
    6505--CAMPHOR_MENTHOL_METHYL SALICYLATE PATCH
    Currently viewing
    Presolicitation
    6505--CAMPHOR_MENTHOL_METHYL SALICYLATE PATCH
    Solicitation
    Similar Opportunities
    6509--Solifenacin Tabletes (VA-25-00037090)
    Buyer not available
    The Department of Veterans Affairs (VA) is preparing to issue a Request for Proposal (RFP) for the procurement of Solifenacin Tablets, designated as RFP 36E79725R0020. This procurement aims to establish a reliable supply of Solifenacin for the VA, Department of Defense (DoD), and other federal health agencies, with the contract expected to last one year and include four optional renewal periods. Solifenacin is a critical medication used in the treatment of overactive bladder, highlighting the VA's commitment to ensuring access to essential pharmaceuticals for veterans and associated healthcare providers. Interested vendors should monitor SAM.gov for the RFP release, anticipated around March 14, 2025, with proposals due by March 28, 2025; for further inquiries, they may contact Contract Specialist Kenneth Lay at Kenneth.Lay@va.gov or by phone at 708-786-4879.
    6505--Diclofenac Sodium (NA) 1% Gel
    Buyer not available
    The Department of Veterans Affairs (VA) is soliciting proposals for the supply of Diclofenac Sodium (NA) 1% Gel, intended for use in its pharmaceutical programs as well as those of the Department of Defense (DoD). Contractors are required to provide pricing for a base year along with four one-year option years, ensuring compliance with federal drug regulations and the Drug Supply Chain Security Act (DSCSA). This procurement is critical for maintaining a reliable supply of pharmaceutical products that meet stringent manufacturing standards and public health requirements. Interested parties must submit their offers by March 4, 2025, at 2:30 PM Central Time, and can contact Contract Specialist Ray Roldan at Raymond.Roldan@va.gov for further information.
    6505--Mycophenolate Mofetil RFP
    Buyer not available
    The Department of Veterans Affairs is seeking proposals for the procurement of Mycophenolate Mofetil capsules and tablets under Solicitation Number 36E79725R0010, aimed at establishing national pricing for these pharmaceutical products. The contract is intended to support various government health care facilities, including those under the Department of Defense and Indian Health Service, ensuring compliance with FDA standards and the Drug Supply Chain Security Act. Offerors are required to submit pricing for both the base year and four option years, with a deadline for submissions extended to March 4, 2025, at 2:30 PM CST, and must acknowledge receipt of this amendment to avoid rejection of their offers. Interested parties can contact Contract Specialist Amber Zavala at amber.zavala@va.gov for further information.
    6505--Hydroxychloroquine SO4 Tablets
    Buyer not available
    The Department of Veterans Affairs (VA) is issuing a Request for Proposal (RFP) for the procurement of Hydroxychloroquine SO4 Tablets, aimed at ensuring a continuous supply for various federal entities, including the Department of Defense and the Bureau of Prisons. The contract will cover an estimated annual requirement of 163,395 bottles of 100-count and 25,853 bottles of 500-count Hydroxychloroquine tablets, with a contract period of one year and four optional one-year extensions. This procurement is critical for maintaining essential medications within veteran and federal healthcare programs. Interested parties should monitor SAM.gov for updates and direct inquiries to the contracting officer, Chris Carthron, at Christopher.Carthron@va.gov or (708) 786-4980, with submissions due by March 26, 2025.
    6505--Fluticasone Propionate 50 MCG/Spray Soln, Nasal, 16GM
    Buyer not available
    The Department of Veterans Affairs is soliciting bids for the supply of Fluticasone Propionate nasal spray, a pharmaceutical product essential for various government healthcare facilities. Offerors are required to submit pricing for a base year and four option years, including a 0.5% Cost Recovery Fee, while ensuring compliance with federal standards and providing a unique National Drug Code (NDC) for each product. This procurement aims to secure reliable pharmaceutical sources to support healthcare services for veterans and other governmental health programs, adhering to strict FDA guidelines and good manufacturing practices. Interested contractors should contact Contract Specialist Michael J Olszewski at Michael.Olszewski@va.gov for further details on submission procedures and compliance requirements.
    6505--Insulin (VA-25-00026482)
    Buyer not available
    The Department of Veterans Affairs is soliciting proposals for the procurement of insulin and related pharmaceutical products under the solicitation titled "6505--Insulin (VA-25-00026482)." This procurement aims to establish a reliable supply source for the Department of Veterans Affairs and the Department of Defense, requiring offerors to submit competitive pricing for a base year plus four option years, including a 0.5% Cost Recovery Fee. Compliance with the Drug Supply Chain Security Act (DSCSA), adherence to current good manufacturing practices (cGMP), and provision of unique National Drug Codes (NDC) for the offered products are critical requirements. Interested parties should direct inquiries to Contract Specialist Billy Fong at Billy.Fong@va.gov, with proposals due by the specified deadline outlined in the solicitation document.
    6505--Rituximab and Biosimilars
    Buyer not available
    The Department of Veterans Affairs is soliciting proposals for the procurement of Rituximab 10mg/ml and its biosimilars, aimed at establishing a reliable pharmaceutical supply source for government healthcare facilities. Bidders are required to provide unique National Drug Code (NDC) numbers for their products and include a 0.5% Cost Recovery Fee in their pricing, with the contract covering a base year and four optional subsequent years. This procurement is critical for ensuring consistent product availability and pricing based on estimated annual usage, while adhering to FDA regulations and the Drug Supply Chain Security Act (DSCSA) for safety and traceability. Interested suppliers must submit their proposals by March 11, 2025, at 2:30 PM CT, and can contact Contract Specialist Deborah S Fassl at Deborah.Fassl@va.gov for further information.
    Tucson CMOP DIVALPROEX
    Buyer not available
    The Department of Veterans Affairs is seeking qualified small businesses to supply Divalproex Sodium 125mg Sprinkle Capsules under Contract Number 36C77025Q0131 for the Tucson CMOP. This procurement requires vendors to comply with strict shipping regulations, provide National Drug Codes (NDC), and ensure product availability while adhering to the Drug Supply Chain Security Act documentation. The pharmaceuticals are essential for the healthcare of veterans, emphasizing the government's commitment to quality and reliability in pharmaceutical supplies. Interested vendors must submit their proposals, including a signed SF 1449 form and a valid wholesale distributor license, by 4:00 PM CST on March 6, 2025, with all submissions directed to Sarah Fry at sarah.fry2@va.gov.
    6505--Bevacizumab Injection
    Buyer not available
    The Department of Veterans Affairs is soliciting proposals for the procurement of Bevacizumab injections, a critical pharmaceutical product used in various healthcare settings for veterans. Vendors are required to meet specific criteria, including providing unique National Drug Codes (NDC) and adhering to the Drug Supply Chain Security Act regulations, as the contract aims to ensure a reliable supply of this medication across government health care facilities. The selected contractor will be responsible for multiple line items of different Bevacizumab formulations, maintaining compliance with FDA manufacturing practices, and submitting quarterly sales reports, including cost recovery fees. Interested vendors should contact Contract Specialist Matthew S. Poulin at Matthew.Poulin@va.gov for further details, with submissions due by the specified deadlines outlined in the solicitation document.
    6505--770-25-1-801-0131 -National CMOP DORZOLAMIDE/TIMOLOL -(VA-25-00027395)
    Buyer not available
    The Department of Veterans Affairs is soliciting bids for the procurement of Dorzolamide 22.3/Timolol 6.8mg/ml ophthalmic solution as part of its National Consolidated Mail Outpatient Pharmacy (CMOP) program. This solicitation requires vendors to submit a signed cover page, pricing schedule, and documentation such as a valid state distributor license and a Trade Agreements Act certificate, ensuring compliance with regulatory standards for pharmaceutical products. The procurement is critical for providing quality healthcare services to veterans, emphasizing the importance of product safety, therapeutic equivalence, and adherence to delivery schedules. Interested vendors must submit their quotes by March 5, 2025, at 3:00 PM Central Time, and can contact Contract Specialist Kelley Cunningham at kelley.cunningham@va.gov for further inquiries.